As of 2026-04-05, the Relative Valuation of InMed Pharmaceuticals Inc (IN.TO) is (8.41) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.19 CAD, the upside of InMed Pharmaceuticals Inc based on Relative Valuation is -300.8%.
The range of the Relative Valuation is (6.79) - (9.88) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.9x - 7.2x | 6.1x |
| Forward P/E multiples | 4.8x - 7.1x | 6.0x |
| Fair Price | (6.79) - (9.88) | (8.41) |
| Upside | -262.0% - -335.7% | -300.8% |
| Date | P/E |